A total of 150 lung adenocarcinoma patients were enrolled based on the inclusion and exclusion criteria, comprising 89 EGFR-mutant cases and 61 wild-type cases, with 72 males and 78 females (mean age 60.02 ± 9.15 years). The gene discussed is EGFR; the disease is lung adenocarcinoma.